Doctors in Southern California have performed the first human bladder transplant, offering new hope to people with serious bladder problems. The surgery was done earlier this month by two doctors from the University of California, Los Angeles (UCLA) and the University of Southern California (USC), The New York Times reported. The patient, 41-year-old Oscar Larrainzar,… read on > read on >
Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared with weight-loss surgery, researchers report in the journal eClinicalMedicine. “We do not yet… read on > read on >
Couch potatoes are more likely to develop Alzheimer’s disease, even if they set aside time to work out each day, a new study says. People who spent more time sitting around were more likely to experience cognitive decline and brain degeneration, no matter how much they exercised, researchers reported May 13 in the journal Alzheimer’s… read on > read on >
Women and Black patients are more likely to suffer life-changing complications from advanced heart and blood vessel procedures, a trio of new studies says. Women face a higher risk of complications after procedures aimed at replacing heart valves or altering the heart’s structure to reduce risk of stroke, researchers reported at a recent meeting of… read on > read on >
MONDAY, May 19, 2025 (HealthDay New) — Looking for a little uplift from Queen’s “Don’t Stop Me Now” or “Happy” by Pharrell Williams? Or perhaps you’re in a reflective mood and would rather hear “Forever Young” by Alphaville or “Time After Time” by Cyndi Lauper. People turn to music to cope, and a new study… read on > read on >
Noninvasive diagnostic test measures two proteins, pTau217 and β-amyloid 1-42, found in human plasma read on >
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal could be worth up to $2.2 billion for Septerna. This includes more than $200 million in upfront and short-term milestone payments, plus future rewards tied to research, development… read on > read on >
A new report says rice sold in U.S. stores contains toxic heavy metals, including arsenic, cadmium, lead and mercury. The report — released by Healthy Babies, Bright Futures — found arsenic in 100% of rice samples tested from stores in 20 metro areas, including New York City, Los Angeles and Miami, CBS News reported. What’s… read on > read on >
Low-income Medicare beneficiaries are more likely to die if they lose access to crucial medication coverage, a new study says. More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces their drug costs, researchers said in background notes. People who lose LIS eligibility are 4% more likely… read on > read on >
People who develop type 1 diabetes in adulthood have a higher risk of heart disease and death, a new study says. However, these patients can improve their odds through healthy lifestyle habits, researchers reported May 14 in the European Heart Journal. “We show that the prognosis can be significantly improved by preventing smoking and obesity… read on > read on >
